AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 26859064
Drug: Linezolid 600mg
RxNorm normalized name: LINEZOLID 600MG TAB
DrugBank: Linezolid (DB00601)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Linezolid 600mg twice daily for 10 days
Trial: 22110122
Drug: DAS-steered treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DAS-steered treatment in ACPA-positive patients
Trial: 22110122
Drug: DAS-steered treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DAS-steered treatment in ACPA-negative patients
Trial: 22110122
Drug: Initial monotherapy
RxNorm normalized name: brigatinib
DrugBank: Brigatinib (DB12267)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Initial monotherapy in ACPA-positive patients
Trial: 20969662
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy with intradermal cross-linked hyaluronic acid and onabotulinumtoxinA
Trial: 20969662
Drug: Cross-linked hyaluronic
RxNorm normalized name: riboflavin 5'-phosphate
DrugBank: Flavin mononucleotide (DB03247)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cross-linked hyaluronic acid monotherapy
Trial: 17624209
Drug: Intrathecal morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal morphine (0.3 mg) plus PCA
Trial: 16360446
Drug: COX‐2 inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: COX‐2 inhibitor (rofecoxib 25 mg/day)
Trial: 16360446
Drug: No COX‐2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No COX‐2 inhibitor
Trial: 12502178
Drug: Choline ingestion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Choline ingestion (50 mg/kg body weight)
Trial: 21823552
Drug: MoxDuo 12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MoxDuo 12 mg/8 mg
Trial: 21823552
Drug: MoxDuo 6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MoxDuo 6 mg/4 mg
Trial: 19210951
Drug: Aripiprazole (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aripiprazole (2.5 to 15 mg/day, mean dose 9.0 mg/day) for 12 weeks
Trial: 19210951
Drug: Continuation treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuation treatment with aripiprazole
Trial: 14726726
Drug: Methylphenidate 0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylphenidate 0.25 mg/kg body weight
Trial: 14726726
Drug: Methylphenidate 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylphenidate 0.5 mg/kg body weight
Trial: 11739299
Drug: Rofecoxib (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rofecoxib (25 mg/d, n=18)
Trial: 11739299
Drug: Naproxen (750
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naproxen (750 mg/d, n=17)
Trial: 2656340
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose (10 micrograms) of SMS 201-995
Trial: 2656340
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose (50 micrograms) of SMS 201-995
Trial: 27818309
Drug: Telephonic support
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telephonic support for loop diuretic adherence monitoring
Trial: 23972529
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg hydrocortisone 30 minutes before a memory encoding task
Trial: 23972529
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg hydrocortisone 210 minutes before a memory encoding task
Trial: 10766888
Drug: Entacapone (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Entacapone (200 mg) with standard Sinemet
Trial: 10766888
Drug: Entacapone (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Entacapone (200 mg) with Sinemet CR
Trial: 29650807
Drug: HCT care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HCT care coordination (CC) intervention
Trial: 26290103
Drug: 30 g/120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 g/120 kcal whey protein
Trial: 26290103
Drug: 70 g/280
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 70 g/280 kcal whey protein
Trial: 26290103
Drug: Flavored water
RxNorm normalized name: FLAVOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flavored water control drink (0 g whey protein)
Trial: 23287635
Drug: Progesterone injection
RxNorm normalized name: Progesterone Injection
DrugBank: Progesterone (DB00396)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Progesterone injection plus oral E2 supplementation (Group A)
Trial: 23287635
Drug: Progesterone injection
RxNorm normalized name: Progesterone Injection
DrugBank: Progesterone (DB00396)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Progesterone injection alone (Group B)
Trial: 20568427
Drug: Acupuncture combined
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture combined with cupping and western medicine (group A)
Trial: 20568427
Drug: Western medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Western medicine (group C)
Trial: 16987363
Drug: E120 group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: E120 group (120 mg etoricoxib)
Trial: 16987363
Drug: E +
RxNorm normalized name: Perle +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: E + P group (120 mg etoricoxib + 1 g paracetamol)
Trial: 14501603
Drug: Conjugated equine
RxNorm normalized name: Conjugated equine estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conjugated equine estrogens (Premarin, 1.25 mg)
Trial: 11073759
Drug: Azithromycin 600
RxNorm normalized name: azithromycin 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azithromycin 600 mg every day combined with ethambutol
Trial: 11073759
Drug: Clarithromycin 500
RxNorm normalized name: clarithromycin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clarithromycin 500 mg twice a day combined with ethambutol
Trial: 1286738
Drug: ViviScal (two
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ViviScal (two tablets once daily for 6 months)
Trial: 1286738
Drug: Fish extract
RxNorm normalized name: channel catfish extract 50 MG/ML Injectable Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish extract (two tablets once daily for 6 months)
Trial: 28724200
Drug: Memantine 30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Memantine 30 mg twice daily for 7 days
Trial: 23169607
Drug: ACE-031 (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACE-031 (3 mg/kg s.c.)
Trial: 18435331
Drug: Infusion removal
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Infusion removal first (Group 1, 30 eyes)
Trial: 18435331
Drug: Infusion removal
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Infusion removal after another cannula (Group 2, 32 eyes)
Trial: 18435331
Drug: Infusion removal
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Infusion removal last (Group 3, 33 eyes)
Trial: 10806605
Drug: Triamcinolone acetonide
RxNorm normalized name: Triamcinolone Acetonide
DrugBank: Triamcinolone (DB00620)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Triamcinolone acetonide (Azmacort HFA 225 mcg Inhalation Aerosol)
Trial: 10806605
Drug: Budesonide (Pulmicort
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide (Pulmicort Turbuhaler 200 mcg)
Trial: 9015909
Drug: Physiological saline,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physiological saline, 1 ml/day intramuscularly for 4 weeks
Trial: 6638669
Drug: Activated charcoal
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Activated charcoal (4 doses of 30 g each, administered every 2 hours)
Trial: 6638669
Drug: Activated charcoal
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Activated charcoal (4 doses of 30 g every 2 hours) in a patient with initial serum theophylline concentration of 31.0 micrograms/ml and signs of toxicity
Trial: 24530600
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg ASP9831
Trial: 24530600
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg ASP9831
Trial: 15866088
Drug: Risedronate (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risedronate (5 mg/day) plus atorvastatin (20 mg/day)
Trial: 10340182
Drug: Cholinesterase inhibitors
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholinesterase inhibitors treatment initiated and monitored by primary care physicians
Trial: 10340182
Drug: Cholinesterase inhibitors
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholinesterase inhibitors treatment
Trial: 2192570
Drug: Continuous propofol
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Continuous propofol infusion with analgesia from bolus doses of papaveretum
Trial: 2192570
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion of papaveretum supplemented by bolus doses of midazolam
Trial: 395771
Drug: Chondroitin sulfate
RxNorm normalized name: Chondroitin Sulfate
DrugBank: Chondroitin sulfate (DB09301)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chondroitin sulfate isomers (4.5 g per day for 64 months)
Trial: 395771
Drug: Chondroitin polysulfate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chondroitin polysulfate (4.5 g per day for 64 months)
Trial: 395771
Drug: Chondroitin 4-sulfate
RxNorm normalized name: chondroitin 4-sulfate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chondroitin 4-sulfate and/or chondroitin 6-sulfate (4.5 g per day for 64 months)
Trial: 21254788
Drug: Aripiprazole as
RxNorm normalized name: Aripiprazole
DrugBank: Aripiprazole (DB01238)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Aripiprazole as adjunctive therapy to antidepressants
Trial: 18833207
Drug: Conventional injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional injection into incisive papilla (Control)
Trial: 11882746
Drug: nizatidine 75
RxNorm normalized name: nizatidine 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: nizatidine 75 mg twice daily
Trial: 11882746
Drug: placebo tablet
RxNorm normalized name: placebo Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: placebo tablet twice daily
Trial: 10225502
Drug: Standard Eye
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard Eye Movement Desensitization and Reprocessing (EMDR) treatment
Trial: 10225502
Drug: Similar treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Similar treatment without the explicit cognitive elements found in EMDR
Trial: 2676530
Drug: Fentanyl and
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fentanyl and two-stage infusion of propofol in a subanaesthetic dose
Trial: 1001000
Drug: Acebutolol (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acebutolol (100 mg to 1200 mg/day in divided doses)
Trial: 29173690
Drug: Omega-3 group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omega-3 group (daily intake of 1080mg EPA + 200mg DHA for 12 weeks)
Trial: 26367143
Drug: Manipulation under
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Manipulation under anaesthesia (MUA) with additional subacromial injection of triamcinolone and bupivacain
Trial: 23201448
Drug: FraxiPure™ (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FraxiPure™ (1000 mg daily for 90 days)
Trial: 21615691
Drug: Paracetamol 1
RxNorm normalized name: Paracetamol 1 g oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol 1 g and Ketorolac 20 mg combination
Trial: 12637702
Drug: Aspirin (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (100 to 300 mg/d)
Trial: 12637702
Drug: Aspirin and
RxNorm normalized name: Aspirin and Caffeine Tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin and Clopidogrel (combined therapy)
Trial: 10818061
Drug: Second-line drugs
RxNorm normalized name: Gallus gallus gizzard lining preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Second-line drugs (Atenolol or Enalapril)
Trial: 10818061
Drug: Isolated systolic
RxNorm normalized name: ISOLATE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isolated systolic hypertension treatment
Trial: 1522663
Drug: Single prophylactic
RxNorm normalized name: polylactic acid-polyglycolic acid copolymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single prophylactic injection of gentamicin
Trial: 25312396
Drug: Nintedanib (BIBF
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nintedanib (BIBF 1120) at a dose of 200mg twice daily
Trial: 20970572
Drug: 1 μg/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 μg/d paricalcitol (n=25)
Trial: 18039918
Drug: Resiquimod 0.01%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Resiquimod 0.01% gel applied two times per week for 3 weeks
Trial: 12021625
Drug: Thiopurine metabolism
RxNorm normalized name: thiotaurine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiopurine metabolism
Trial: 10071518
Drug: chlorpheniramine 8
RxNorm normalized name: CODEINE 54.3/CHLORPHENIRAMINE 8MG SA TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: chlorpheniramine 8 mg
Trial: 10071518
Drug: All H1-receptor
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All H1-receptor antagonists
Trial: 1705193
Drug: Combined contraceptive
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined contraceptive pills containing desogestrel and gestodene
Trial: 6789354
Drug: Flurazepam 26
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flurazepam 26 mg
Trial: 6789354
Drug: Flurazepam (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flurazepam (all doses)
Trial: 25622803
Drug: Short implants
RxNorm normalized name: short ragweed pollen extract Sublingual Tablet [Ragwitek]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short implants placed with osteotome sinus floor elevation (OSFE) without grafting (test group)
Trial: 25622803
Drug: Short implants
RxNorm normalized name: short ragweed pollen extract Sublingual Tablet [Ragwitek]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short implants placed with osteotome sinus floor elevation (OSFE) with grafting (control group)
Trial: 17634459
Drug: Certolizumab pegol
RxNorm normalized name: Certolizumab Pegol
DrugBank: Certolizumab pegol (DB08904)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Certolizumab pegol 400 mg every 4 weeks through week 24
Trial: 215096
Drug: Morphine (120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine (120 mg doses)
Trial: 26341987
Drug: AZD5069 80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AZD5069 80 mg orally twice daily for 28 days
Trial: 23561868
Drug: Pilates exercise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pilates exercise program (twice a week for one year)
Trial: 14734920
Drug: Injection rate
RxNorm normalized name: tacrolimus
DrugBank: Tacrolimus (DB00864)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Injection rate of 0.5 mL/s
Trial: 14734920
Drug: Injection volume
RxNorm normalized name: VOLUME EXPANDERS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection volume (2, 10, 20 mL)
Trial: 14734920
Drug: Flow rates
RxNorm normalized name: Quarter Mate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flow rates of 1 to 2 mL/s with a minimum of 20 mL gadolinium dimeglumine
Trial: 11743482
Drug: 1% chlorhexidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% chlorhexidine gluconate/61% ethanol antiseptic hand preparation
Trial: 9162612
Drug: Guar gum
RxNorm normalized name: Guar Gum
DrugBank: Guar gum (DB13446)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guar gum bread (7.6 g guar per meal)
Trial: 9162612
Drug: Control (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (75 g carbohydrate breakfast meals of control bread)
Trial: 6839561
Drug: Tizolemide (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tizolemide (50 mg i.v.)
Trial: 31347916
Drug: Knowledge/tools and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Knowledge/tools and solutions for improving experimental design
Trial: 27614276
Drug: Equestrian therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Equestrian therapy (24 biweekly sessions over 3 months)
Trial: 22192423
Drug: Split-dose picosulfate,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Split-dose picosulfate, magnesium oxide, and citric acid solution (1 sachet at 7:00 pm and another sachet 4 hours before colonoscopy)
Trial: 22192423
Drug: Traditional dosing
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Traditional dosing regimen (1 sachet at 5:00 pm and 10:00 pm the night before colonoscopy)
Trial: 17592349
Drug: Thiopentone 3
RxNorm normalized name: Thiopentone
DrugBank: Thiopental (DB00599)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Thiopentone 3 mg/kg
Trial: 12467851
Drug: Parametric method
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parametric method of estimating Doppler ultrasound umbilical maximal flow waveform envelope; No specific dosage or duration mentioned.
Trial: 12467851
Drug: Modification of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modification of the estimation procedure; No specific dosage or duration mentioned.
Trial: 23263559
Drug: Tacrolimus once-daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tacrolimus once-daily regimen
Trial: 23263559
Drug: Tacrolimus twice-daily
RxNorm normalized name: clindamycin
DrugBank: Clindamycin (DB01190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tacrolimus twice-daily regimen
Trial: 21719530
Drug: Unfractionated heparin
RxNorm normalized name: Unfractionated heparin
DrugBank: Heparin (DB01109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Unfractionated heparin embedded in a phosphorylcholine matrix (XPC group)
Trial: 19127975
Drug: Free primary
RxNorm normalized name: acid red 337 free acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Free primary health care (prepayment scheme allowing free primary care including drugs)
Trial: 11423055
Drug: Dobutamine (standard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dobutamine (standard therapy)
Trial: 9290362
Drug: Hyaluronan ophthalmic
RxNorm normalized name: hyaluronate Ophthalmic Ointment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyaluronan ophthalmic solution (0.1% hyaluronic acid), instilled five times a day to the right eye
Trial: 9290362
Drug: Artificial tear
RxNorm normalized name: Artificial Tears
DrugBank: Polyethylene glycol 400 (DB11077)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Artificial tear solutions (control group)
Trial: 7975402
Drug: Anti-arteriosclerosis diet
RxNorm normalized name: Anti Bac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-arteriosclerosis diet containing 20 g of ichthyenic oil
Trial: 2890806
Drug: DL‐dihydroxyphenylserine 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DL‐dihydroxyphenylserine 600 mg
Trial: 16644430
Drug: Low-dose dobutamine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose dobutamine (LDD) stress echocardiography (peak infusion 10 microg/kg/min)
Trial: 16644430
Drug: Low-dose dobutamine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose dobutamine (LDD) stress echocardiography
Trial: 12676043
Drug: Acupuncture treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture treatment for migraine/headaches
Trial: 12676043
Drug: Acupuncture treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture treatment for nausea/vomiting
Trial: 10653203
Drug: Abecarnil (12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Abecarnil (12 mg, three times daily)
Trial: 10653203
Drug: Diazepam (22
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam (22 mg, three times daily)
Trial: 6134827
Drug: Monthly sessions
RxNorm normalized name: Alternanthera sessilis extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monthly sessions
Trial: 27112723
Drug: Immediate loading
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate loading of 2 unsplinted implants
Trial: 27112723
Drug: Unloaded implants
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unloaded implants (control)
Trial: 20522536
Drug: FG‐3019 (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FG‐3019 (3 mg/kg)
Trial: 20522536
Drug: FG‐3019 (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FG‐3019 (10 mg/kg)
Trial: 16906395
Drug: Ginkgo biloba
RxNorm normalized name: Ginkgo Biloba
DrugBank: Ginkgo biloba (DB01381)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ginkgo biloba extract (EGb) 360 mg/day plus haloperidol 0.25 mg/kg/day
Trial: 16906395
Drug: Placebo plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo plus haloperidol 0.25 mg/kg/day
Trial: 10971385
Drug: Amifostine (740
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amifostine (740 mg/m2)
Trial: 10719311
Drug: DBPCFC with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DBPCFC with egg (first dose 500 mg or less)